Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Parkinson Disease

In brief

This study will be evaluating the safety and efficacy of insulin and glutathione in subjects with Parkinson's Disease compared to placebo.

Key facts

Study ID

NCT05266417

Run by

Gateway Institute for Brain Research

People needed

56

Starts

2022-02-07

Expected to finish

2027-11-30

Last updated by the study team

2026-07-22

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Institute for Neuroimmune Medicine — Davie, Florida, United States (enrolling)
• Las Mercedes Medical Research — Hialeah, Florida, United States (enrolling)
• NextGen Research Group — Miami, Florida, United States (enrolling)
• Charter Research — The Villages, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.